LONA Stock Summary and Trading Ideas (Leonabio | NASDAQ:LONA)

LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to address treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). LeonaBio is also exploring the use of other drug candidates that enhance the neurotrophic HGF system, including ATH-1020, to improve neuronal health and function in multiple neurological diseases. In addition, it is also focused on designing and testing new early compounds directed towards novel targets for a variety of clinical applications. The company operates as a single operating segment, developing and commercializing therapeutics.

Leonabio trades on the NASDAQ stock market under the symbol LONA.

As of October 9, 2026, LONA stock price was flat at $5.75 with 63,658 million shares trading.

LONA has a beta of -0.34, meaning it tends to be less sensitive to market movements. LONA has a correlation of 0.00 to the broad based SPY ETF.

LONA has a market cap of $54.17 million. This is considered a Micro Cap stock.

The top ETF exchange traded funds that LONA belongs to (by Net Assets): VTI, VXF, IWC, DFMC, DCOR.

LONA support price is $5.08 and resistance is $6.42 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LONA shares will trade within this expected range on the day.